Norwegian Medical Translation Services

Yes. We produce Norwegian-language regulatory documents for Statens Legemiddelverk, meeting the Agency's requirements for drug registration and medical device marketing authorization within the EMA framework.

Yes. We produce medical translations in Bokmal as standard, which is used by the majority of Norwegian speakers. Nynorsk versions are available upon request for documents requiring both official written standards.

Yes. We coordinate Norwegian clinical trial translation as part of multi-country Nordic or European studies, ensuring consistent terminology across all language versions.

Norway follows the EU GDPR via the EEA Agreement, enforced nationally through the Norwegian Data Protection Authority (Datatilsynet). Patient records, clinical data, and any personal health information processed during a translation project are handled under strict GDPR-equivalent safeguards. Files are transferred via encrypted channels, access is restricted to the assigned translator and reviewer, and all project data is deleted after final delivery unless a retention agreement is in place.

Yes. While the majority of Norwegian regulatory submissions to Statens Legemiddelverk use Bokmal, patient-facing materials distributed in certain regions may require Nynorsk versions. We manage both variants within a single project workflow, applying consistent medical terminology across both written standards and flagging any Bokmal-to-Nynorsk adaptation choices for client review.